Lessons from assembling a microbial natural product and pre-fractionated extract library in an academic laboratory.

IF 3.2 4区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Michael A Cook, Daniel Pallant, Linda Ejim, Arlene D Sutherland, Xiaodong Wang, Jarrod W Johnson, Susan McCusker, Xuefei Chen, Maya George, Sommer Chou, Kalinka Koteva, Wenliang Wang, Christian Hobson, Dirk Hackenberger, Nicholas Waglechner, Obi Ejim, Tracey Campbell, Ricardo Medina, Lesley T MacNeil, Gerard D Wright
{"title":"Lessons from assembling a microbial natural product and pre-fractionated extract library in an academic laboratory.","authors":"Michael A Cook, Daniel Pallant, Linda Ejim, Arlene D Sutherland, Xiaodong Wang, Jarrod W Johnson, Susan McCusker, Xuefei Chen, Maya George, Sommer Chou, Kalinka Koteva, Wenliang Wang, Christian Hobson, Dirk Hackenberger, Nicholas Waglechner, Obi Ejim, Tracey Campbell, Ricardo Medina, Lesley T MacNeil, Gerard D Wright","doi":"10.1093/jimb/kuad042","DOIUrl":null,"url":null,"abstract":"<p><p>Microbial natural products are specialized metabolites that are sources of many bioactive compounds including antibiotics, antifungals, antiparasitics, anticancer agents, and probes of biology. The assembly of libraries of producers of natural products has traditionally been the province of the pharmaceutical industry. This sector has gathered significant historical collections of bacteria and fungi to identify new drug leads with outstanding outcomes-upwards of 60% of drug scaffolds originate from such libraries. Despite this success, the repeated rediscovery of known compounds and the resultant diminishing chemical novelty contributed to a pivot from this source of bioactive compounds toward more tractable synthetic compounds in the drug industry. The advent of advanced mass spectrometry tools, along with rapid whole genome sequencing and in silico identification of biosynthetic gene clusters that encode the machinery necessary for the synthesis of specialized metabolites, offers the opportunity to revisit microbial natural product libraries with renewed vigor. Assembling a suitable library of microbes and extracts for screening requires the investment of resources and the development of methods that have customarily been the proprietary purview of large pharmaceutical companies. Here, we report a perspective on our efforts to assemble a library of natural product-producing microbes and the establishment of methods to extract and fractionate bioactive compounds using resources available to most academic labs. We validate the library and approach through a series of screens for antimicrobial and cytotoxic agents. This work serves as a blueprint for establishing libraries of microbial natural product producers and bioactive extract fractions suitable for screens of bioactive compounds.</p><p><strong>One-sentence summary: </strong>Natural products are key to discovery of novel antimicrobial agents: Here, we describe our experience and lessons learned in constructing a microbial natural product and pre-fractionated extract library.</p>","PeriodicalId":16092,"journal":{"name":"Journal of Industrial Microbiology & Biotechnology","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10724011/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Industrial Microbiology & Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1093/jimb/kuad042","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Microbial natural products are specialized metabolites that are sources of many bioactive compounds including antibiotics, antifungals, antiparasitics, anticancer agents, and probes of biology. The assembly of libraries of producers of natural products has traditionally been the province of the pharmaceutical industry. This sector has gathered significant historical collections of bacteria and fungi to identify new drug leads with outstanding outcomes-upwards of 60% of drug scaffolds originate from such libraries. Despite this success, the repeated rediscovery of known compounds and the resultant diminishing chemical novelty contributed to a pivot from this source of bioactive compounds toward more tractable synthetic compounds in the drug industry. The advent of advanced mass spectrometry tools, along with rapid whole genome sequencing and in silico identification of biosynthetic gene clusters that encode the machinery necessary for the synthesis of specialized metabolites, offers the opportunity to revisit microbial natural product libraries with renewed vigor. Assembling a suitable library of microbes and extracts for screening requires the investment of resources and the development of methods that have customarily been the proprietary purview of large pharmaceutical companies. Here, we report a perspective on our efforts to assemble a library of natural product-producing microbes and the establishment of methods to extract and fractionate bioactive compounds using resources available to most academic labs. We validate the library and approach through a series of screens for antimicrobial and cytotoxic agents. This work serves as a blueprint for establishing libraries of microbial natural product producers and bioactive extract fractions suitable for screens of bioactive compounds.

One-sentence summary: Natural products are key to discovery of novel antimicrobial agents: Here, we describe our experience and lessons learned in constructing a microbial natural product and pre-fractionated extract library.

在学术实验室组建微生物天然产物和预分馏提取物库的经验教训。
微生物天然产物是一种特殊的代谢产物,是许多生物活性化合物的来源,包括抗生素、抗真菌剂、抗寄生虫剂、抗癌剂和生物学探针。组建天然产物生产者文库历来是制药业的工作。制药业已经收集了大量历史悠久的细菌和真菌,以确定新的药物线索,并取得了卓越的成果--60% 以上的药物支架都来自于此类文库。尽管取得了这一成功,但已知化合物的反复重新发现以及由此导致的化学新颖性的不断降低,促使制药业从这一生物活性化合物来源转向更容易合成的化合物。先进质谱工具的出现,加上快速的全基因组测序以及对编码合成特殊代谢物所需机器的生物合成基因簇的默观鉴定,为重新审视微生物天然产物库提供了新的契机。组建一个合适的微生物和提取物库进行筛选需要投入资源和开发方法,而这些通常是大型制药公司的专利。在此,我们从一个角度报告了我们在组建天然产物生产微生物库方面所做的努力,以及利用大多数学术实验室可用的资源建立提取和分馏生物活性化合物的方法。我们通过一系列抗菌剂和细胞毒剂的筛选验证了文库和方法。这项工作为建立微生物天然产物生产者库和生物活性提取物分馏库提供了蓝图,适合生物活性化合物的筛选。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Industrial Microbiology & Biotechnology
Journal of Industrial Microbiology & Biotechnology 工程技术-生物工程与应用微生物
CiteScore
7.70
自引率
0.00%
发文量
25
审稿时长
3 months
期刊介绍: The Journal of Industrial Microbiology and Biotechnology is an international journal which publishes papers describing original research, short communications, and critical reviews in the fields of biotechnology, fermentation and cell culture, biocatalysis, environmental microbiology, natural products discovery and biosynthesis, marine natural products, metabolic engineering, genomics, bioinformatics, food microbiology, and other areas of applied microbiology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信